The p53 family member p63 is a transcriptional regulator of epithelial development and differentiation, acting as a common downstream effector of activated EGFR/RAS and TGFβ pathways, and playing an important role in primary breast cancers. This evidence concerns the gene EGFR and breast carcinoma.